Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
E

Failure to Monitor and Document Psychotropic Medication Use

Seattle, Washington Survey Completed on 06-06-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure adequate monitoring and documentation for residents prescribed psychotropic medications, including antidepressants and antipsychotics. For one resident, an antidepressant was initiated and the dose increased, but there was no monitoring or documentation of target behaviors or potential adverse side effects in the Medication Administration Record (MAR). Staff confirmed that such monitoring and documentation were expected but missing from the records. Another resident had been on antipsychotic medication for an extended period, but the required Abnormal Involuntary Movement Scale (AIMS) assessment was completed late, exceeding the recommended six-month interval. The consultant pharmacist had previously advised the facility to document AIMS assessments every six months to remain compliant, but staff acknowledged that the assessment was overdue. Additional residents were also prescribed antipsychotic medications without evidence of monitoring for side effects or target behaviors in the physician's orders or MAR. Staff interviews confirmed that monitoring and documentation were expected for all residents on psychotropic medications, but these were not present in the records reviewed. The facility's policy required nursing staff to observe and document the effectiveness of interventions and monitor for side effects, but this was not consistently followed.

An unhandled error has occurred. Reload 🗙